Biographical Memoirs
following his decommission as an army chaplain, he became overseas secretary of the Society for the Propagation of the Gospel. John's mother, Josephine Muriel Frearson Sulston (née Blocksidge), taught English at Watford Grammar School. Her own father, Joseph Blocksidge, had been a school inspector, and earlier ancestors had been engineers in the Midlands. The couple settled with John and his younger sister Madeleine in Rickmansworth, Hertfordshire, on the northern outskirts of London (figure 1).
From his father, John inherited 'an indifference to material wealth, and [his] overriding sense that one should work for the common good'. He credited his mother with encouraging his curiosity, as she was always prepared to answer the barrage of questions her children fired at her over the kitchen table. Both parents were disappointed that, after a struggle during his adolescence, John found he could no longer follow the Christian faith in which they raised him (17)*. From an early age, John showed an immense curiosity about how things worked, both natural and mechanical. He saw himself as 'a maker and a doer', as well as a thinker. From purpose-made construction sets such as Meccano (figure 2) he graduated to home-made radios and other electrical gadgets. He dissected a dead bird he had found by the roadside; 'I . . . was fascinated to discover that living things were also mechanisms', he later wrote (17).
Having attended a private preparatory school, York House in Rickmansworth, at age 13 John won a scholarship to the London Merchant Taylors' School at Northwood near his home. He gravitated naturally to science, but caused consternation to his teachers when he opted for biology rather than mathematics at A level, together with physics and chemistry. The anxiety proved unfounded when he won a scholarship to read natural sciences at Pembroke College, University of Cambridge, where he arrived in the autumn of 1960.
Initially attracted by neurophysiology, he lost focus during his second year, devoting much of his time to setting up theatre lighting for the Cambridge Amateur Dramatic Club and on one infamous drunken occasion ending up in the police station. As his tutor had predicted, he went on to receive a rather poor result in his second-year examination. Pulling himself together in his final year, he opted for organic chemistry, responded to the imaginative tuition of his supervisor, Ian Fleming (FRS 1993) , and achieved an upper second class degree, but it was 'a bit of a near squeak ' (17, 18) .
Research beginnings
Research was not John's first option as a career-indeed, he thought his less than stellar undergraduate record would preclude it. He had applied to do a year with Voluntary Service Overseas (VSO), but at the last moment his place fell through. On the off-chance, he contacted the head of organic chemistry at Cambridge, Alexander Todd FRS, to ask if there might be a place for him as a research student. Todd immediately assigned him to Colin Reese (FRS 1981) , who gave him a project on oligonucleotide synthesis. John was in his element; 'No more text books, just my own lab books, and the toys, the lovely toys, to play with', he wrote (18) .
Reese and his group were making synthetic RNA molecules using chemical methods to string nucleotides together in a predetermined order. John took the opportunity to deploy every technology available in the lab, including mass spectrometry and nuclear magnetic resonance, to attack the practical problems he encountered with enthusiasm and ingenuity. During the three years of his PhD on 'Aspects of oligoribonucleotide synthesis', he contributed to nine papers from the lab-for example, see (1).
Meanwhile, the chemist Leslie Orgel FRS, who had recently left Cambridge for a position at the Salk Institute at La Jolla in California, was looking for people to staff his new laboratory, focused on a new direction, prebiotic evolution. When he asked Reese for recommendations for post-docs to join his group, John's name was among them. John grasped the opportunity at once: working with Orgel would at last bring him closer to the biological topics that had fascinated him when he was younger. He arrived at the Salk in the autumn of 1966.
Orgel was trying to understand how nucleic acids might have replicated at a point in evolutionary history before the existence of polymerases, the enzymes that carry out this task in all living organisms. The origin of life was a lively area of interest at the time: only in the previous decade had organic molecules such as amino acids been shown to be produced from inorganic precursors under the conditions thought to prevail in the atmosphere of the early Earth (Miller & Urey 1959) .
For John, the specifics of his experiments were less important than his exposure to deep thinking about the nature of life and evolution, and the contacts he made at the Salk. Orgel frequently invited him to dinner and introduced him to many visiting scientists. One of these was Francis Crick FRS, who, with Sydney Brenner FRS, directed the Cell Biology Division at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. What John had assumed was an informal conversation with Crick turned out to be an interview. Orgel had suggested that John apply for a staff post at the Salk, but Brenner invited him to come and join the group he had set up at the LMB to work out how genes made an animal, the nematode worm Caenorhabditis elegans. Not completely convinced that he was ready to leave California for good, John agreed to go as a visiting scientist for a year.
Marriage and family
During his PhD John had shared a flat in Cambridge with a student in geophysics, who occasionally brought a young research assistant from his department, Daphne Bate, to dinner. Within a year John and Daphne were an item. They married just before they left for California in 1966, and their daughter Ingrid was born the year of their arrival. Rather than living on the La Jolla campus, they rented a house five miles north near the beach, drove first an old pickup and then a Volkswagen beetle, grew their own vegetables and spent holidays touring round national parks.
On their return to Cambridge in 1969 they bought a house in the village of Stapleford, not far from the lab, and their son Adrian was born soon afterwards (figure 3). The family made one more move in 1975, to a larger house in the same village, where they stayed for the rest of John's life. Daphne became librarian in the Department of Applied Mathematics and Theoretical Physics at the University of Cambridge. Ingrid grew up to be a designer of interactive exhibits for science museums and a science teacher; she married and had two children, Micah and Kira. Adrian became a software engineer. He is also a freelance musician, playing trombone in a number of orchestras and ensembles in Edinburgh.
Worm biology and the lineage
John saw the position in Brenner's group as a chance to get back to his early interest in neurobiology in a system that might yield more precise answers, and his initial year would eventually turn into a permanent staff position. Over the next few years he laid the foundation for his scientific career.
Caenorhabditis elegans adults are transparent and barely a millimetre in length. The species has two forms, a self-fertilizing hermaphrodite with 959 somatic cells, and a male with 1031, and exhibits a full range of animal physiology and behaviour, including sensing, moving, feeding, sexual reproduction and ageing. A major goal of Brenner's project was to understand the worm's nervous system in detail. John White (FRS 2005) was brought on to determine the anatomy of what turned out to be its 302 neurons. Sydney worked on the genetics of the worm, isolating mutants of all kinds, particularly those altering behaviour. Others worked on biochemistry and electrophysiology. John's task was to investigate the neurotransmitters used in the neurons that White was mapping. While acetylcholine was known to be the activating transmitter for the motor neurons and γ-amino butyric acid (GABA) the inhibitory transmitter, the catecholamines-epinephrin, norepinephrin and dopamine-were as yet uncharacterized in the worm.
In preparation for the LMB position, John had taken a neurobiology course at the Salk the previous summer, where he learned stains that were specific for catecholamines. But he had to modify these staining methods for the difficult task of identifying the very small individual neurons in the worm. He designed two small metal blocks with just a 1 mm gap between for a coverslip containing worms. He cooled the blocks in liquid nitrogen, plopped in the coverslip to freeze the worms instantly, and then placed the assembly in a vacuum to dehydrate everything. After exposing the freeze-dried worms to formaldehyde, he soon had lovely preparations showing eight neurons that fluoresced after exposure to formaldehyde. Using chemistry on bulk worms, he showed that worms contained dopamine, but not the other catecholamines. To correlate the six neurons in the head with the ones White was identifying with the electron microscope, he needed to position them relative to others. For this purpose, he stained the DNA of each nucleus. Because the worm's cells are essentially in the same place in every animal, John was soon able to assign these neurons as the four cephalic neurons and two other sensory neurons in another sensory organ.
The question then became: what did these neurons do? John conducted a series of elegant experiments. He isolated mutant worms that lacked dopamine to see if they had aberrant behaviours. Suspecting that these neurons might involve touch sensitivity, he stroked them with an eyebrow hair glued onto the end of a toothpick, but found no defect. He then looked directly for mutants that failed to respond to touch; after stroking more than 20 000 mutagenized animals, he disappointedly concluded that touch must be mediated by other neurons. What the dopamine-positive neurons did remained a mystery.
But John had made a critical observation in the course of these studies. Looking at animals stained for DNA, he realized that the adults had more neurons in their ventral cord than newly hatched larvae. Careful counting showed that the larva had just 15 neurons in the ventral nerve cord, whereas the adult had 57. His observation contradicted the accepted view, which held that all the non-gonadal cells were formed during development of the egg, and no new cells were added after hatching. The lineage, or the pattern of cell divisions that occurred during the development of the worm, was also of great interest in Brenner's group. John recognized that the observation of cell divisions in larvae, where the cells of the ventral cord are linearly arrayed and well spaced, presented an easier problem than in the embryo, where the cells are very small and closely packed.
The larva presented the new challenge of following cell divisions in a moving animal. John realized that if he provided it with a patch of bacteria, the worm, instead of crawling vigorously in search of a meal, would 'graze' lazily, the slow pace letting him follow individual cells under his Nomarski (differential interference contrast) microscope as they migrated and divided (figure 4). After an exhilarating weekend of observations, he had the outline of how the cells were added to the cord through migration and division of sublineages. In six of these sublineages in the hermaphrodite, one cell always died shortly after birth. These reproducible cell deaths would lead to the highly productive study of programmed cell death in the worm. Indeed, the first mutant altering cell death, nuc-1(e1392), was described in the paper reporting the ventral cord lineage (3). A second paper from these early years would have similar long-term implications for John's career. Brenner estimated that the worm had only a few thousand genes that were essential to its well-being, only slightly more than were estimated to be important in the bacterium Eschericia coli. How much DNA did the worm have in its genome relative to E. coli and other animals? Brenner tasked John, with his background in nucleotide chemistry, to examine this problem. Using bulk extraction methods with known numbers of worms and known numbers of nuclei per worm as well as rehybridization kinetics, John estimated that the worm genome contained about 20 times as much DNA as the 4 Mb E. coli genome, or about 80 million base pairs (2). Over the next few years (work published 1977-1983) , John followed up on these findings with a series of papers with collaborators. With Robert Horvitz (ForMemRS 2009) , who came to the LMB as a post-doc in 1974 and subsequently went to the Massachusetts Institute of Technology (MIT), he elucidated the entire post-embryonic non-gonadal lineages of both the hermaphrodite and male (4); they went on to characterize the first lineage mutants, and to show that most lineages resulted from the complex interaction of multiple genes (6, 7). With White, he used laser ablation of specific cells as a high-tech substitute for classical extirpation experiments to show that while cell autonomy was frequent, position was also critical for some cells during post-embryonic differentiation (5). With Martin Chalfie (ForMemRS 2018), he followed up his earlier work on the touch-insensitive mutants (8) . With Edward Hedgecock, he began to explore the genetics of programmed cell death (9). But by 1979 John, according to his autobiography, was left with a sense of 'unfinished business' as well as a feeling that he had achieved little (17). The pattern of cell divisions in the embryo, the most fundamental period of development, remained a mystery.
In 1977 John had made an initial foray into the embryonic lineage to settle a dispute that had arisen among others in the worm community on the lineage of the gut cells, the largest, easiest to follow cells. He determined that the proposed lineage was incorrect. But perhaps because of the incredible difficulty of tracing the lineage of hundreds of very small, compactly arrayed cells, he had hesitated. However, by 1979 he was ready to take on the embryonic lineage, a challenge Judith Kimble, who had worked with John as a post-doc at LMB and done similar work at a much smaller scale, regarded as 'unimaginably difficult'.
John began slowly making incremental improvements to his methods. He sketched out events using a colour code to indicate depth (Gitschier 2006) . To keep track of the cell he was observing, he placed a pair of gossamer hairs in one eyepiece and used a gliding stage to place the desired cell at the cross-hairs. The project remained incredibly demanding. John locked himself in a room, free of distractions, for eight hours a day, every day for a year and a half, despite occasional doubts that the lineage was worth the effort. Each day he would focus on a group of cells, recording with his colour code the divisions and movements of each cell in the group (figure 5). The last step was connecting each of the terminal cells with their fates in older animals. For this task he followed all the lineages in a single animal, a virtuoso performance, and carried out detailed analysis with electron microscopy, comparing the morphology of his lineaged animal with other series. By the autumn of 1982 he had completed the full lineage of the animal from egg to adult and submitted a manuscript on the work (10). While its main impact was to provide a valuable and lasting resource for investigation of C. elegans development (with more than 3400 citations; Google Scholar), some biological insights came directly from the construction of the lineage.
When John presented this work at The International C. elegans meeting in 1983, he was asked how he could be sure he got the lineage right. He replied that he was confident because he had followed so many embryos and so many sublineages and had no unaccounted for or conflicting cells. Indeed, the lineage has proved entirely accurate (apart from a clerical error in the 1983 paper), a remarkable feat for such a complex series of observations.
Mapping
With his intimate knowledge of the embryonic lineage, John was uniquely positioned to explore its genetic basis. But others were already using the lineage to study development; John began looking for another path. A major bottleneck at the time in animal studies was isolating the DNA for genes discovered through genetics. Hundreds of genes had been discovered and 'mapped' to chromosomal locations through mutational analysis in worms, flies, mice and humans, and often the greatest insight into how those genes functioned came from recovering the DNA for the gene and sequencing it. In bacteria and yeast, DNA reintroduced into the cell could be used to recover genes of interest, but in animals the process of recovering a specific gene was arduous. One of the most common and generalizable methods was 'chromosome walking', an iterative process of finding a nearby marker for which the DNA was known, finding clones containing the marker, choosing the clone that extended the farthest-thereby taking a step-and repeating the process. John realized that instead of hundreds of individual investigators pursuing their own 'walks', a central specialized effort could determine the overlaps of thousands of random clones and reconstruct the genome once for everyone: in other words, a physical map. From his earlier work, he knew the worm genome was about 80 Mb (later revised upward to 100 Mb), and to cover that genome would require 2500 clones with 40 kb inserts, the largest available clone sizes at the time. Of course with random clones and overlaps, 6-8 times that many clones would have to be analysed. The prospect of analysing 18 000 random clones was daunting, but the result would be that worm investigators could simply find the genetic map position of the gene of interest and then obtain the clones that might contain the gene, hugely speeding the process of discovery. Like the lineage, it would be a resource for all the community, but the project would involve the development of methods in molecular biology, a field in which John had not worked before.
Neither the size nor the complexity of the challenge dissuaded him. An immediate question was how to determine the clone overlaps. With thousands of clones to distinguish one from another, John needed a method that would be precise and sensitive. Not knowing the molecular biology needed to assay the individual clones, he consulted with Sydney Brenner and Jon Karn, a staff scientist at LMB. Jon came up with a clever method that produced from each clone about 20 radioactively labelled restriction fragments whose size could be precisely analysed with the same kind of gels used for DNA sequencing. The fragments ordered by size constituted a unique 'fingerprint'. To make the clones themselves, John chose cosmid vectors in the bacterium E. coli, which accepted up to 40 kb inserts. Progress was slow to start, but speeded up when Alan Coulson, who had been a research officer developing DNA sequencing with Fred Sanger FRS until Sanger retired, agreed to join the effort (figure 6). For Alan, attacking the large genome of the worm was a natural extension of the efforts that he and Sanger had made at understanding the smaller genomes of viruses.
Together John and Alan divided the tasks and steadily worked to increase throughput. John taught himself computer programming and wrote software to facilitate data entry, map building, editing and, with the help of graduate student Richard Durbin (FRS 2004) , detection of clone overlaps. By 1986, they had fingerprinted more than 7000 clones that fell into about 900 contiguous sequences (contigs) and with unattached clones covered about 80% of the genome. They reported their progress in back-to-back publications with Maynard Olson's similar work at Washington University in St Louis on the smaller yeast genome, using different methods but an overall similar strategy (12) (Olson et al. 1986) .
The fingerprint map also represented substantial progress on another goal: linking the genetic and physical maps to create a genome map. From the start, John saw the genome map as a communal project, where his lab would collaborate with worm labs across the world. John used the Worm Breeder's Gazette, an informal, uncitable semi-annual collection of one-page abstracts from worm labs, first to announce the project and then to report progress, not waiting for formal publication. The community shared DNA with John and Alan from genetically known positions for them to place on the physical map, thus tying the two maps together. In Figure 6 . Alan Coulson worked with John on mapping and later sequencing the worm genome.
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turn, John and Alan provided clones to labs, obviating many 'walking' steps. John rigorously observed this division of labour, focusing his efforts on building the map, while leaving it to the community to study the genes he uncovered. However, a problem was apparent even in the 1986 publication; the clones were not a random representation of the genome. Indeed, for unclear reasons, a significant fraction of the worm genome could not be propagated in E. coli as cosmids. As a result, when the number of fingerprinted clones doubled to more than 17 500, the number of contigs fell only to 680, with new clones adding very little new genomic DNA.
When Bob Waterston (co-author of this memoir, then at Washington University in St Louis) arrived on sabbatical in the autumn of 1985, the challenges in closing the remaining gaps in the map were emerging. Bob explored several strategies for gap closure, but none proved useful in the long run. However, toward the end of the year, Bob learned of the success of his Washington University colleague Maynard Olson's lab at cloning large pieces of DNA as yeast artificial chromosomes (YACs). YACs could hold much larger pieces of DNA than cosmids and were propagated in yeast, not E. coli. With the help of Maynard's graduate student, David Burke, Bob began making YACs with worm inserts and sharing them with John. With the help of a subsequent sabbatical visitor to Cambridge, Yuji Kohara, the YACs were soon zipping the remaining contigs together. As the number of contigs fell, the small number of gaps allowed more targeted approaches and, eventually, every last gap was closed (13, 14) .
As the map advanced and became more widely useful, the community needed more frequent and detailed reports. John started sending a tape containing the entire database to the Waterston and Horvitz labs, which in turn made the database available by dial-up modem and remote logins to their North American colleagues. He used the emerging internet (BITNET, a precursor to the World Wide Web) to send incremental updates. The data came with caveats, since joins and positions yet to be validated were included. The community became adept at using these less than fully validated data.
Worm sequencing
It is not clear when John started thinking about the map as a starting point for determining the entire sequence of the C. elegans genome. In announcing the mapping project, John had written vaguely about how the map could provide 'information about the genome as a whole' (11) . Certainly, the atmosphere at the LMB was bullish when Sanger completed the genome of bacteriophage lambda in 1982, and John recounts in his biography a late night session at a Cold Spring Harbor meeting discussing in some detail the feasibility of sequencing the worm genome. In 1985, when others began talking about sequencing the human genome, he provided valuable perspective to the groups and committees deliberating the wisdom of a human genome project. But he was fully occupied with constructing the worm clone map; he was also aware that even with 'just' a 100 Mb genome, rather than the 3000 Mb human genome, a worm sequencing project would be about 300 times larger than the largest genome yet sequenced and would require a large group, with John increasingly in the role of manager. Even as the National Institutes of Health (NIH) formed the Office of Genome Research, with Jim Watson (ForMemRS 1981) as its head, John had taken no steps toward a worm sequencing project.
But it is clear when John became committed to sequencing the worm genome. In early 1989 Bob Horvitz learned from Jim Watson that, while he was including other model organisms in the project, he might exclude C. elegans. Watson's reasoning was that the worm community (as opposed to those studying E. coli, yeast and Drosophila) was too small to warrant such a large investment. Horvitz realized that research in worm labs would be at a severe disadvantage should yeast and fly labs have a full genome sequence, and they have none.
Although not interested himself, Horvitz very much wanted John to do it. He called John and laid out the bleak scenario should Watson exclude the worm. Drawing Bob Waterston into the conversation, they soon developed a plan to use the advanced state of the clone map to convince Watson to include the worm. Conveniently, The International C. elegans meeting was at Cold Spring Harbor in May 1989; John, Bob and Alan posted the map in the poster room and made sure Watson saw it. Later they met him; he agreed to entertain a pilot project that would produce 3 Mb of the worm genome sequence. The NIH would be willing to fund Bob's lab in St Louis and up to a third of an equal effort by John in Cambridge; the balance would have to be provided by British sources. John was suddenly committed to sequencing the worm.
Once committed, John never wavered. Unlike many in the nascent genome community who wished to wait for the emergence of new sequencing methods before embarking on largescale projects, John argued that there was no need to wait, that the methods Fred Sanger had invented-dideoxynucleotide sequencing reactions and gel electrophoresis-based separation of the products to read out the sequence-could be made vastly more efficient through steady improvement. To know which parts of the process needed improving, he set about learning the details of sequencing.
John and Bob Waterston eventually settled on a two-part strategy. In an initial 'shotgun' phase, random subclones from a cosmid were sequenced and those sequences stitched together by their overlaps, thus regenerating much of the sequence for the cosmid. In the second phase the remaining gaps in the sequence would be closed and other problems resolved through directed sequencing reactions. The sequence itself was acquired by machines that used fluorescent labels, rather than radioactive ones, and lasers to detect the labelled, migrating fragments in real time. Of the two commercially available instruments, the Applied Biosystems ABI370 quickly became the favourite because of its higher throughput and ease of use. The two groups operated increasingly like factories rather than conventional labs. Costs per base dropped annually by a third or more while production more than doubled.
The second phase, closing gaps and resolving problems, was more challenging and depended on computational advances. An early challenge was developing a way to view the sequence data, represented as traces of the four fluorescent labels as they passed the detector. ABI provided only a coded version of the digital data that had to be viewed on print-outs. With hundreds of pages for each cosmid, print-outs proved impractical. To make the data more readily accessible for review, John sat down one summer afternoon and decoded the ABI file. This decoding enabled others in the groups to write software that could display the traces on a computer screen alongside the assembly, allowing the user to 'correct' errors in the sequence and plan experiments to resolve discrepancies. In other work, Phil Green, a colleague in Bob's department, developed rigorous error estimates for each base call (a program called phred) that he in turn utilized in an assembly program (phrap), greatly improving the assemblies and saving much manual editing. Phil also wrote programs that were able to effectively reveal the genes that were hidden in the sequence, while Richard Durbin and Jean Thierry Mieg developed a database, ACeDB, that held all the sequence along with relevant information from the literature.
As with the map, John saw the sequence project as a collaboration with the community, where the central labs generated the sequence and the community provided biological understanding. To get the data to the community as soon as possible, the labs submitted the finished, annotated sequence of each cosmid to the public databases (GenBank and EMBL) without waiting for publication. However, the initial assemblies were too unreliable to release to the community, the internet was still in its infancy and there was no precedent for releasing work in progress. Nonetheless, the two groups posted the names of the clones they were working on so that everyone knew what was coming. With the introduction of phred and phrap, the initial assemblies became much more reliable. In an article in the February 1994 Worm Breeder's Gazette, the consortium listed all the cosmids underway and the genes in the draft sequence; they made that data available to the community via the emerging World Wide Web. From those interactions, the sequencing labs became convinced that access to assembled but unfinished data was valuable and in 1995 they began releasing via ACeDB and FTP (file transfer protocol) all sequences for each cosmid as soon as the shotgun data were assembled. The policy would have important ramifications for human genome sequencing and beyond.
John now had to take on organizational and management tasks he had largely avoided. Terrified by the idea that he would be responsible for organizing others, initially he brought on people who were largely self-motivated, including Richard Durbin, to spearhead informatics efforts, and Molly Craxton and Trevor Hawkins, to work on sequencing methods. Gradually, as his group grew and positions became more specialized, he became more of a 'boss'. Nonetheless he maintained a horizontal management structure and led more by example. Coordination between the Cambridge and St Louis labs involved frequent emails, and John and Bob developed a routine of long Sunday afternoon (or evening in John's case) phone calls to resolve any difficulties or misunderstandings.
John had to convince the MRC leadership that they should fund two-thirds of the Cambridge effort, or about $600 000 a year, for the three years of the pilot project. To obtain the other third, he worked with Bob to write a grant proposal to the NIH-the first formal grant proposal he had ever written! As the worm pilot effort began to succeed, he and Bob had to persuade the funding agencies to support a scale-up to sequence the remaining 97% of the genome. Initial inquiries to the NIH and MRC were not encouraging, given the large price tag. To see the project through, John and Bob considered (but rejected) other options, including the possibility of moving the effort to a private company, an option that would also allow large-scale human sequencing.
The possibility that they would leave the NIH-funded project mobilized Jim Watson, who lobbied MRC Secretary Dai Rees FRS to take action to keep John in England. That led to an overture to Bridget Ogilvie (FRS 2003) , the director of the Wellcome Trust, which had had a sudden influx of funds. These overtures eventually led to MRC funding for John's portion of the worm sequence and Wellcome Trust funding in the context of a commitment to sequence the human genome, drawing John deeper into the Human Genome Project (HGP). The assured funding for John also helped Bob get the okay to apply for a large grant to finish the worm in the next five years.
Progress was rapid. By the summer of 1993, they had finished more than 2 Mb of contiguous sequence on chromosome III, far more than any other group had achieved; five years later they reported over 97 Mb of sequence (15, 16) . The last 3 Mb were completed slowly over the next few years, with John playing a central role in seeing the sequence through to completion (19) . Availability of the sequence has led to an explosion in understanding of fundamental biology that is relevant across the animal kingdom, including humans.
Human sequencing
With the encouragement of the Wellcome Trust, in the summer of 1992 John put in a proposal for $80 million over five years to finish the sequence of the worm as well as yeast, and to produce 40 Mb of human sequence. Such an operation would put them in a leadership role in the international human genome effort and was well beyond what could be accommodated at the LMB. The Trust established a purpose-built sequencing laboratory, the Sanger Centre (later the Wellcome Trust Sanger Institute) on an old estate near Hinxton, about eight miles south of Cambridge, with John as director. John, working with Michael Ashburner, bid successfully to bring the European Bioinformatics Institute to the Hinxton site to bolster the standing of the Centre. Having only reluctantly committed to the worm sequencing project just three years earlier, John was now deeply entrenched in a much larger and more politically fraught sequencing project. To help him with this, he established a board of management, each member of which had specific responsibilities in the running of the Centre (figure 7). He would take on larger roles in policy, politics and management in the years ahead.
By the summer of 1994, John was increasingly concerned about his group's progress on human sequencing. Completing each clone to the very high standard set for the worm was expensive and difficult. Meanwhile, others, including Craig Venter at The Institute for Genome Research (TIGR) and Incyte, a company in the San Francisco Bay area, were touting the advantages of getting fragments of sequence from complementary DNA (cDNA) clones (expressed sequence tags, or ESTs) for gene discovery. They argued that since less than 2% of the human genome encoded the protein-producing genes, sequencing capacity could be much more effectively utilized by sequencing cDNAs. However, both TIGR and Incyte limited access to their data, with an eye to commercial gain.
When Bob and members of his lab came to Cambridge for the annual meeting of the two labs in September 1994, including the usual punting trip up the Cam to a pub in Grantchester, he and John took the opportunity one evening to discuss at length their growing concerns about human genome sequencing, sitting at the picnic table in John's garden. Bob had not seen John so troubled in their many years of working together. On the long flight back to St Louis, Bob began considering options. He realized that available technology and software enabled them to sequence human clones to 99.9% accuracy with a gap or two every 100 000 bases. The two labs could produce this slightly lower quality product covering the entire human genome at a reasonable cost in five years, with the more demanding finished product going on in parallel but at a slower pace. John was initially taken aback by the scale and audacity of Bob's proposal, but soon realized that it represented a realistic path forward. They began to explore the idea with the Trust, the MRC and the NIH. Both the Trust and MRC were receptive and invited John to make a presentation on 1 December 1994.
Five days before the scheduled meeting, John was riding his motorbike to work on a Saturday morning and was blindsided by a van. He was knocked unconscious, and his femur was pushed through his pelvis. He was rushed to hospital and his pelvis was repaired, leading eventually to a full recovery. Remarkably, when John awoke the next day, he insisted that the meeting on Thursday still take place. Bob, who had been scheduled to join him, flew over to reassure himself that John was going to recover, not expecting that the meeting would go ahead. But John was not to be denied; from his wheelchair he made dramatic presentations to both the Trust and MRC.
Bob presented the same proposal later in December at a meeting of genome centre leaders at the NIH, whose National Center for Human Genome Research (NCHGR) was now led by Francis Collins. Although the funding bodies were cautiously supportive, the two labs received less than they needed to complete the draft sequence in five years. The resultant delay on both sides of the Atlantic would have unintended consequences.
With several groups to be funded in the US, and more in Europe and Asia announcing plans, John realized that coordination between all these groups would be critical to success. More importantly, he wanted to counteract the 'gold rush mentality' that was rampant in human genomics. Groups were after regions that contained important disease genes, with commercial implications backed by patent applications. John had experienced this mentality first hand in aiding a group in London in their race with Myriad Genetics for the BRCA2 gene. To deal with these issues, John worked with Michael Morgan of the Wellcome Trust to sponsor a planning meeting along with US officials, which quickly expanded to include groups across the world as well as representatives of the databases and funding agencies. Bermuda was chosen as the site, near to the US and yet not on US soil.
The first Bermuda meeting took place in February 1996. The first couple of days were spent discussing protocols and methods as well as intended sequence targets to remove duplication. In the final session, John and Bob led a discussion on data sharing and patenting, and described the successful rapid data release model that had evolved for the worm. Their model was foreign to many of the participants: in some cases, funding agency support came with the expectation that any sequences would be commercially exploited and potentially patented. The debate went back and forth, but the worm provided a powerful precedent; eventually what became known as the Bermuda Principles were hammered out and agreed to by all the scientists, as well as representatives of the funding agencies, pending approval from their home institutions. The Bermuda Principles advocated data release within 24 hours after assembly and eschewed patenting. They not only guided the public HGP and other publicly funded sequencing projects but also became a model for projects in other fields.
With funding in place, a data-sharing policy and the beginnings of a collaborative framework, human sequencing began in earnest at the Sanger Centre and across the world (figure 8). Progress over the next two years was steady, but not spectacular, reflecting the level of funding. John's team started building clone maps and using those for sequencing. Based on their success, John submitted a proposal to the Trust to double the Sanger's funding, allowing them to complete one-third of the human genome. A meeting was scheduled on 13 May 1998, to present the plan to the Trust's Board of Scientific Governors.
The weekend before that meeting the sequencing machine manufacturing company ABI, and Craig Venter, who held one of the pilot NIH grants, announced the formation of a company, eventually called Celera, to exploit new machines and an untested strategy to sequence the human genome, claiming they would be cheaper and faster than the public effort. The initial investment would be some $300 million. The company did not commit to immediate public release of data; instead they declared their intent to file patents. Moreover, the quality of the product was uncertain with no commitment to closing gaps and resolving sequence ambiguities. Venter presented his plan at a scheduled meeting of the genome centres' leaders at Cold Spring Harbor on 12 May, and was met with scepticism. But given the money committed and the promise of new machines, he had to be taken seriously: in the US context, some argued that the publicly funded effort should step aside in his favour. Fortunately, when John presented his plan to the Trust and explained the situation, the governors fully endorsed his proposal and committed full funding. When John flew over to report the news to the assembled genome scientists at the subsequent Cold Spring Harbor scientific meeting, he received a standing ovation. His resolve and the Trust's support stiffened the backbones of US officials, and the discussion turned to mounting an effective effort to ensure that the human genome would be of high quality and remain in the public domain.
Over the next two years, John spent an increasing amount of time keeping the public effort on track and representing that effort to the press and public, especially in Britain. In parallel, Venter and his company pursued their strategy in what was increasingly viewed as a 'race'. Celera mounted a substantial public relations effort, trumpeting their progress, while belittling the public effort. John countered these claims, showing how the public effort was progressing and, critically, making clear the importance of a free and globally available human sequence as a resource for discovery.
Eventually, the 'race' ended in June 2000 in a hastily arranged agreement to call it a draw. Both the public effort and Celera agreed that they would announce at a joint press conference that they had each completed a draft version of the human genome. The announcement was preceded by televised statements from President Bill Clinton and Prime Minister Tony Blair, trumpeting the accomplishments of both groups, with John at Blair's side in London and Collins and Venter at Clinton's side in Washington. For what was, after all, just a press announcement, the attention the announcement garnered was stunning, revealing the global fascination with the work of the sequencers.
The agreement also stipulated that the two rival groups would publish papers on their results at the same time in Science. By November, it became clear that Celera was going to release its data only to academics on its own website and under severe restrictions. Commercial users would have to pay. John was aghast at the compromises that Science was willing to make to its standard policy of open data release in order to publish the Celera paper. He argued against submitting the paper from the public effort to Science in protest, and advocated instead for publication in Nature at the same time.
When the publications finally appeared separately in Nature (International Human Genome Sequencing Consortium 2001) and Science (Venter et al. 2001) , the public groups, John included, were delighted and surprised to learn that, at least as published by Celera, the commercially generated genome sequence was no better than the genome from the public effort, even though Celera merged all the public data with theirs to produce their product. The public had no need to go to Celera's website for human sequence; they could go to the public databases that had an equivalent product for free and without restrictions. The HGP continued to improve their sequence over the next three years, and with their publication of a high quality genome sequence in 2004 (Collins et al. 2004 ), Celera's version was obsolete. John had prevailed in the fight for open genome sequence data.
Retirement
With the announcement of the draft human sequence, John felt he had fulfilled his commitments and accomplished his major goals. He had told the Wellcome Trust board in confidence two years earlier that he intended to step down as director of the Sanger Centre. By the summer of 2000, the Trust had recruited Allan Bradley (FRS 2002) , then at Baylor College of Medicine in Texas, as director. Unbeknown to John, his staff had organized an elaborate party in his honour. At first there were short tributes by John's closest colleagues, including Bob, and then the group moved to a larger room for the performance of a full English pantomime (an established Christmas tradition at the Sanger), King John and the Knights of the Holy Genome, with Abba imitators singing 'He is the sequence king . . . '. John was hauled up on stage to play the lead from cue cards for his lines.
John retained a small office at the Sanger Centre, and continued to work on remaining problems in the worm sequence with Alan Coulson. He had become actively concerned with the relationships between science and society, and once his lab commitments lessened, he took on new responsibilities. In 2001, he became a member of the Human Genetics Commission (HGC), a government advisory body that investigated issues such as direct-to-consumer genetic testing services and the protection of personal genetic information in insurance and employment. From 2007 until he resigned from the Commission in 2009, he served as its chair.
John was an impassioned advocate not only for the public release of genomic information, but for a wholly different relationship between science, commercial biotechnology and pharmaceutical companies, and the people of the world. He participated in discussions convened by James Love, director of the Consumer Project on Technology (now Knowledge Ecology International) on intellectual property and access to public goods, and encouraged his colleague Tim Hubbard, head of human sequence analysis at the Sanger Centre, to co-publish a number of articles with Love (for example, see Hubbard & Love 2004) . He visited treatment programmes for HIV/AIDS in South Africa as the guest of Oxfam, an organization that he had long supported, and became a figurehead for the charity's Cut the Cost of Medicines campaign to reform the trade rules on patented medicines to benefit developing countries (Oxfam 2001) .
Throughout the Celera episode, John was concerned that the HGP was losing out to the superior public relations expertise of the company and the private sector more generally. He himself had little regard for 'spin', believing that the facts should speak for themselves, and even less for self-presentation. Gradually, he came to realize that he had a distinctive and persuasive voice, and could use it. He even, when the situation demanded, put on a jacket and tie in place of his habitual polo shirt, jumper and sandals, and made a number of appearances on radio and TV. Describing Celera's incorporation of public data into their own sequencing effort as a 'con job' on BBC Radio 4's Today programme was only one example of his unguarded style. But his approachability also made him an obvious choice for the Royal Institution Christmas Lectures, on 'The Secrets of Life', in 2001. At the end of 2000, he approached one of the authors of this memoir (Georgina Ferry) about writing an account for a wide readership of the struggle to keep genomic information public. The book, co-authored by the two of them, was published as The common thread (17), with subsequent editions in several languages.
The offer of a knighthood in 2001 brought some soul-searching: John knew that his former chairman at LMB, Max Perutz FRS had declined one on the grounds that he did not want to be set apart from his colleagues with a title. However, he decided to accept on the grounds that 'it was a richly-deserved recognition for the achievements of the Sanger Centre as a whole' (17). In October of 2002, John's Nobel prize was announced. The prize for physiology or medicine was awarded jointly with Sydney Brenner, then based at the Molecular Sciences Institute, in Berkeley, California, and Bob Horvitz of MIT for their pioneering studies of the nematode worm, including John's contribution to the cell lineage and the genetic control of cell death (figure 9). In consequence he was showered with invitations to speak.
On a speaking tour of China and Taiwan organized by the British Council in December 2003, John met the bioethicist John Harris from the University of Manchester. In 2008, they jointly founded the Institute for Science, Ethics and Innovation (iSEI), at the University of Manchester. The most significant outcome of this collaboration was Who owns science? The Manchester manifesto (iSEI 2012), an attempt to address the drawbacks of the existing system of intellectual property, signed by a distinguished group of scientists, social scientists, lawyers and philosophers.
A further major piece of work for which John provided collaborative leadership was the Royal Society report People and the planet (Royal Society 2012). He chaired a 21-member working group of globally diverse contributors, addressing the impact of human population on the global environment. The report's key recommendations were the elimination of absolute poverty and reduction of inequality, a reduction of material consumption in developed and emerging economies, a global financial commitment to family planning, and the inclusion of population as a factor in any debate about environmental change. As well as these grand projects, he accepted countless invitations to speak to school and university students, and to support local causes. A lifelong cyclist and supporter of the Sustrans cycle network, in 2005 he cut the ribbon to open a two-mile cycle path, decorated with coloured bars to represent the bases of the BRCA2 gene, that connected Addenbrooke's Hospital with the village of Great Shelford. Visitors to his local library sometimes did a double-take when they saw a familiar bearded figure quietly reshelving books. He supported the work of Cambridge Past, Present and Future, which protects and promotes the natural and built heritage of the Cambridge area. Following his retirement from iSEI in 2013, he enjoyed sharing his favourite activities of gardening and hill walking with his family (figure 10).
Personality
John's achievements attained further recognition in his lifetime, including a commission by the artist Marc Quinn for the National Portrait Gallery (clones of John's DNA in a frame), and a building named after him at the Sanger Institute. But his distinction made not the smallest difference to his personal lifestyle. He dressed casually, drove an old car and cycled whenever possible. He grew his own fruit and vegetables, and took his own cheese sandwiches to work for lunch every day. His idea of a relaxation was to drive to an upland area of Britain for a day's walking, sleeping overnight in the car. Most of the money that came his way, including his Nobel prize winnings, he gave away to charitable causes with no fanfare; for example, he endowed the Sanger Institute Prize, which gives undergraduates from low-and middle-income countries the opportunity to spend a three-month internship at the Sanger Institute. His unexpected death from stomach cancer in March 2018, shortly before his seventy-sixth birthday, prompted emotional tributes from all over the world. The Sanger Institute gathered tweets and emails into the Book of celebration that honours his memory. Here are a few:
'Brilliant scientist, man of principle. Great discussions at Human Genetics Commission', Veronica van Heyningen FRS. 'Extraordinary scientist and wonderful human being. His creativity and vision knew no bounds-utter triumph of substance over spin', Alison Woollard. 'A great scientist and a wonderful man who supported open science and those working on access to medicines. I still regularly share his group's Manchester Manifesto', Ellen 't Hoen. 'He changed the course of scientific research twice, for C. elegans and genomics . . . Great strength of vision, and focus, to deliver selflessly for all', Richard Durbin.
